Congress should encourage companies to repurpose existing drugs for rare diseases, potentially doubling the number of treatment options for patients. Lately, there has been a national uproar over the rising […]
Congress should encourage companies to repurpose existing drugs for rare diseases, potentially doubling the number of treatment options for patients. Lately, there has been a national uproar over the rising […]